Published in Int J Hematol on April 07, 2017
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant (2012) 11.34
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost (2009) 4.95
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood (1986) 1.98
The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers. Thromb Haemost (1999) 1.51
Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol (2012) 1.34
Recent guidelines and recommendations for laboratory detection of lupus anticoagulants. Semin Thromb Hemost (2014) 1.24
Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH. Thromb Haemost (1995) 1.14
A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost (1993) 0.95
Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time. Clin Lab (2009) 0.93
The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants. Blood Coagul Fibrinolysis (2003) 0.92
Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'. Blood Coagul Fibrinolysis (1990) 0.89
Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls. J Autoimmun (2000) 0.85
Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications. Br J Haematol (2003) 0.84
The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thromb Res (2005) 0.83
Laboratory identification of lupus anticoagulants. Semin Thromb Hemost (2012) 0.82
Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination. J Thromb Thrombolysis (2000) 0.82
Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy. Blood Coagul Fibrinolysis (1990) 0.81
Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test. Thromb Res (2014) 0.81
Lupus anticoagulant diagnosis in activated partial thromboplastin time mixing test: optimization of the index of circulating anticoagulant cut-off value. Clin Lab (2014) 0.80
Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits. Semin Thromb Hemost (2013) 0.79
Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma? Thromb Haemost (2014) 0.79
Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant. Thromb Haemost (2013) 0.78
Different genotypes are responsible for the normal Russell viper venom assays seen in some cases of congenital factor X deficiency. Am J Hematol (2008) 0.77
Commonalities and contrasts in recent guidelines for lupus anticoagulant detection. Int J Lab Hematol (2014) 0.77
The activated seven lupus anticoagulant assay detects clinically significant antibodies. Clin Appl Thromb Hemost (2007) 0.77
Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant. Blood Coagul Fibrinolysis (2004) 0.77
Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients. Thromb J (2007) 0.75
Scientific Misconduct and Social Media: Role of Twitter in the Stimulus Triggered Acquisition of Pluripotency Cells Scandal. J Med Internet Res (2017) 0.79
Applying spatial epidemiology to hematological disease using R: a guide for hematologists and oncologists. J Blood Med (2014) 0.78
Prediction of Female Breast Cancer Incidence among the Aging Society in Kanagawa, Japan. PLoS One (2016) 0.75
Health management in cancer survivors: Findings from a population-based prospective cohort study-the Yamagata Study (Takahata). Cancer Sci (2015) 0.75
Applying data envelopment analysis to preventive medicine: a novel method for constructing a personalized risk model of obesity. PLoS One (2015) 0.75
Effect of genomics-related literacy on non-communicable diseases. J Hum Genet (2017) 0.75
Approving molecularly targeted drugs: different approval processes for cytotoxic agents. Int J Clin Oncol (2016) 0.75